Effects of Debaryomyces hansenii treatment on intestinal mucosa microecology in mice with antibiotic-associated diarrhea

PLoS One. 2019 Nov 14;14(11):e0224730. doi: 10.1371/journal.pone.0224730. eCollection 2019.

Abstract

Aim: To confirm the effects of Debaryomyces hansenii on intestinal microecology in mice with antibiotic-associated diarrhea (AAD).

Methods: This study took the mucosal microecology as the entry point and an antibiotic mixture was used to induce diarrhea in mice. D. hansenii suspension was used to treat the mice and the bacterial communities of mucosa was analyzed using high-throughput sequencing.

Results: The Shannon-Wiener index indicated that the sequencing depth is reasonable and reflected the majority of microbial information. The principal coordinate analysis results showed that mice in the treatment group and the normal group had a similar microbial community structure, while differences in microbial community structure were observed between the model group and the treatment group. The inter-group bacterial structures were analyzed at the phylum level and genus level. The results revealed that antibiotic treatment increased the proportion of Proteobacteria and decreased the proportion of Bacteroides, while D. hansenii treatment inhibited the increase in Proteobacteria. Linear discriminant analysis coupled with effect size measurements (LEfSe) suggested d that the beneficial bacteria Candidatus Arthromitus were the only common bacteria in the normal group (P<0.05).

Conclusion: The treatment with D.hansenii could contribute to the maintenance of the structure of the mucosal microbiota in comparison with the normal group and inhibit the proliferation of opportunistic bacteria. However, high-dose antibiotic treatment causes mucosal dysbiosis and the proliferation of opportunistic bacteria during the self-recovery period, such as Pseudoalteromonas, Alteromonas, Vibrio.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / adverse effects*
  • Anti-Bacterial Agents / pharmacology
  • Bacteria / classification
  • Bacteria / growth & development*
  • Debaryomyces*
  • Diarrhea* / chemically induced
  • Diarrhea* / microbiology
  • Diarrhea* / therapy
  • Dysbiosis* / chemically induced
  • Dysbiosis* / microbiology
  • Dysbiosis* / therapy
  • Gastrointestinal Microbiome / drug effects*
  • Mice

Substances

  • Anti-Bacterial Agents

Grants and funding

This work was supported by grants from the National Natural Science Foundation of China (No. 81573951). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.